About us

Institute of Biostatistics and Analyses, Masaryk University

The Institute of Biostatistics and Analyses, Masaryk University (IBA) was established in May 2006 by the decision of the Academic Senate of Masaryk University. This department is now an independent administrative unit of MU. The newly based department started its activities according to the Dean's decision on 1.7.2006. The Institute of Biostatistics and Analyses took over all the activities and liabilities of its predecessor - the Centre of Biostatistics and Analyses (interfaculty institute associated with the Faculty of Medicine as well as with the Faculty of Science).

As an academic institute, IBA has mainly the following mission:

• To provide training in the field of applied data analysis and IT applications for biological and clinical fields of research.
• To carry out research on the application of mathematical and statistical methods and information technologies in biological and clinical fields of research (particularly in risk assessment, applied stochastic modeling, multivariate analyses of biological data, predictive medicine, evidence-based medicine, data mining, software development for research).
• To provide a full scale portfolio of services expected from informatics from the point of view of the biological and clinical fields of research (for instance: data analysis, software development and data processing in databases, clinical registration, computer graphics, and Internet services).

The IBA is involved in student training at all levels (undergraduate, graduate, life-long learning). Research objectives are funded by successfully applying for research grants either directly or in co-operation with grantees at Masaryk University or any other academic institution in the Czech Republic or abroad.

Based on successfully started contacts with many investigative institutions as well as private companies, IBA initiated a broad spectrum of activities:

• prospective clinical trials
• retrospective registration of clinical data
• cost-effectiveness clinical studies
• applied development of software
• implementation of health technology assessment standards
• human risk assessment
• etc.